Yahoo Finance • 21 hours ago
As European markets face renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, the pan-European STOXX Europe 600 Index recently ended 2.21% lower, reflecting broader market unease. In th... Full story
Yahoo Finance • yesterday
As European markets navigate the challenges of inflated AI stock valuations and shifting expectations for U.S. interest rates, investors are keenly observing how these factors influence broader market sentiment. In this environment, divide... Full story
Yahoo Finance • 3 days ago
Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have experienced notable declines, with the STOXX Europe 600 Index dropping by 2.21%. Despite this downturn, t... Full story
Yahoo Finance • 4 days ago
Amid renewed concerns about inflated AI stock valuations, the European markets have seen a downturn, with major indices like the STOXX Europe 600 Index and Germany's DAX experiencing notable declines. Despite this challenging environment,... Full story
Yahoo Finance • 12 days ago
As European markets experience a rise, with the STOXX Europe 600 Index climbing 1.77% amid relief from the U.S. government reopening, investor sentiment remains cautious due to cooling enthusiasm around artificial intelligence. Despite the... Full story
Yahoo Finance • 22 days ago
Evotec SE reported its third-quarter 2025 results, showing quarterly sales of €163.89 million and a net loss of €43.09 million, alongside news that it received a US$25 million payment from Bristol Myers Squibb for progress within their neu... Full story
Yahoo Finance • 26 days ago
As European markets experience mixed performances, with the STOXX Europe 600 Index slightly down after peaking at a new high, investors are closely watching the European Central Bank's interest rate decisions and inflation trends. In this... Full story
Yahoo Finance • last month
Advances made in preclinical pipeline addressing neurodegenerative diseases Evotec receives US$ 25 m payment to support continued progression of joint programs HAMBURG, DE / ACCESS Newswire / October 27, 2025 / Evotec SE (Frankfurt Stock... Full story
Yahoo Finance • 2 months ago
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story
Yahoo Finance • 3 months ago
If you’ve been glancing at Evotec’s ticker lately wondering whether it’s finally time to act, you’re far from alone. In a market defined by swift rotations and rapid shifts in sentiment, Evotec has been a lesson in volatility and opportuni... Full story
Yahoo Finance • 4 months ago
Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductions Reporting segment formerly known as Shared R&D renamed to Discovery & Preclinical Development ("D&PD") to better... Full story
Yahoo Finance • 4 months ago
Evotec SE (NASDAQ:EVO) announced Wednesday that it is planning, together with Sandoz (SIX:SDZ) AG, a potential sale of the Just – Evotec Biologics site located in Toulouse, France. The information was disclosed in a press release stateme... Full story
Yahoo Finance • 4 months ago
Evotec (OTCPK:EVOTF [https://seekingalpha.com/symbol/EVOTF]) announced an update to its fiscal year 2025 [https://seekingalpha.com/pr/20171500-evotec-adjusts-revenue-guidance-and-confirms-profit-guidance-anticipating-a-more-profitable] rev... Full story
Yahoo Finance • 5 months ago
Evotec SE (NASDAQ:EVO) is among the 13 Best German Stocks to Invest in Now. The company’s shares have gained over 9% in the past month, as of the close of business on July 2, amid positive recent developments.Here Is What You Need To Know... Full story
Yahoo Finance • 5 months ago
Evotec SE (NASDAQ:EVO) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the company said it would participate in the NURTuRE-AKI consortium to investigate acute kidney injury (AKI) and advance drug di... Full story
Yahoo Finance • last year
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis.... Full story
Yahoo Finance • last year
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago.... Full story
Yahoo Finance • last year
Investing.com -- U.S. stock futures rose Wednesday, continuing to rebound after the tech-led rout at the start of the week. Here are some of the biggest premarket U.S. stock movers today Walt Disney (NYSE:DIS) stock fell 0.1% in volatil... Full story
Yahoo Finance • 2 years ago
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast European life science company Evotec SE (NASDAQ:EVO) announced a priority reset to optimize its business to meet evolving market demand and focus on profit... Full story
Yahoo Finance • 3 years ago
KEY SCIENTIFIC ACHIEVEMENTS DRIVE THE EXPANSION OF THE PIPELINE OF MOLECULAR GLUE DEGRADERS PERFORMANCE-BASED AND PROGRAMME-BASED PAYMENTS OF IN TOTAL US$ 75 M TO EVOTEC HAMBURG, GERMANY / ACCESSWIRE / March 16, 2023 / Evotec SE (Frankfur... Full story